Fresh analysis reveals that people who come off popular slimming jabs like Mounjaro or Wegovy tend to recover lost weight at a significantly accelerated pace than those who halt traditional lifestyle plans.
Published data in a leading health publication shows that while obese people frequently drop substantial amounts of their body weight while on the medication, the weight returns at an average rate of 0.8 kg per month once they quit.
"Individuals purchasing these medications must be aware of the risk of quick weight regain when the medication is stopped," cautioned researcher Dr. Susan Jebb.
This pace of regain implies a return to original mass within about a year and a half.
Comparing Treatments
The study, which looked at dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with other pills.
Scientists point out that people who shed pounds through lifestyle changes alone typically have a less rapid creep back—perhaps 100 grams monthly—once they finish.
Understanding the Quick Regain
Experts suggest the mechanism of the drugs is key to understanding the accelerated rebound.
The injections imitate a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of the hormone levels far above than the body's typical production may cause the system to produce less of its own natural GLP-1, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' results in hunger is no longer kept in check, making overeating far more likely."
A Chronic Disease?
Medical guidelines advise the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
Professionals argue that, given the likelihood of weight regain, the therapy should be considered life-long.
This opinion is supported by drug manufacturers, who note that the results "emphasize the chronic character of excess weight," similar to managing diseases like hypertension.
User Experiences
Users who have come off the medication describe a sudden return of cravings.
"It felt as if a switch flipping and you become ravenous," recalled an individual.
This challenge is worsened if individuals have not adopted sustainable dietary or behavioural modifications during therapy.
Significant Use
Figures show that a significant number of people in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Use is higher among females compared to males.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
Ultimately, experts caution that while GLP-1 drugs are effective tools for shedding pounds, they are not a permanent solution and maintained weight loss hinges on ongoing behavioural management.
